API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
65
PharmaCompass offers a list of Bisoprolol Fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bisoprolol Fumarate manufacturer or Bisoprolol Fumarate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bisoprolol Fumarate manufacturer or Bisoprolol Fumarate supplier.
PharmaCompass also assists you with knowing the Bisoprolol Fumarate API Price utilized in the formulation of products. Bisoprolol Fumarate API Price is not always fixed or binding as the Bisoprolol Fumarate Price is obtained through a variety of data sources. The Bisoprolol Fumarate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bisoprolol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bisoprolol, including repackagers and relabelers. The FDA regulates Bisoprolol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bisoprolol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bisoprolol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bisoprolol supplier is an individual or a company that provides Bisoprolol active pharmaceutical ingredient (API) or Bisoprolol finished formulations upon request. The Bisoprolol suppliers may include Bisoprolol API manufacturers, exporters, distributors and traders.
click here to find a list of Bisoprolol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bisoprolol DMF (Drug Master File) is a document detailing the whole manufacturing process of Bisoprolol active pharmaceutical ingredient (API) in detail. Different forms of Bisoprolol DMFs exist exist since differing nations have different regulations, such as Bisoprolol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bisoprolol DMF submitted to regulatory agencies in the US is known as a USDMF. Bisoprolol USDMF includes data on Bisoprolol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bisoprolol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bisoprolol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bisoprolol Drug Master File in Japan (Bisoprolol JDMF) empowers Bisoprolol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bisoprolol JDMF during the approval evaluation for pharmaceutical products. At the time of Bisoprolol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bisoprolol suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bisoprolol Drug Master File in Korea (Bisoprolol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bisoprolol. The MFDS reviews the Bisoprolol KDMF as part of the drug registration process and uses the information provided in the Bisoprolol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bisoprolol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bisoprolol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bisoprolol suppliers with KDMF on PharmaCompass.
A Bisoprolol CEP of the European Pharmacopoeia monograph is often referred to as a Bisoprolol Certificate of Suitability (COS). The purpose of a Bisoprolol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bisoprolol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bisoprolol to their clients by showing that a Bisoprolol CEP has been issued for it. The manufacturer submits a Bisoprolol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bisoprolol CEP holder for the record. Additionally, the data presented in the Bisoprolol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bisoprolol DMF.
A Bisoprolol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bisoprolol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bisoprolol suppliers with CEP (COS) on PharmaCompass.
A Bisoprolol written confirmation (Bisoprolol WC) is an official document issued by a regulatory agency to a Bisoprolol manufacturer, verifying that the manufacturing facility of a Bisoprolol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bisoprolol APIs or Bisoprolol finished pharmaceutical products to another nation, regulatory agencies frequently require a Bisoprolol WC (written confirmation) as part of the regulatory process.
click here to find a list of Bisoprolol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bisoprolol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bisoprolol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bisoprolol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bisoprolol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bisoprolol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bisoprolol suppliers with NDC on PharmaCompass.
Bisoprolol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bisoprolol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bisoprolol GMP manufacturer or Bisoprolol GMP API supplier for your needs.
A Bisoprolol CoA (Certificate of Analysis) is a formal document that attests to Bisoprolol's compliance with Bisoprolol specifications and serves as a tool for batch-level quality control.
Bisoprolol CoA mostly includes findings from lab analyses of a specific batch. For each Bisoprolol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bisoprolol may be tested according to a variety of international standards, such as European Pharmacopoeia (Bisoprolol EP), Bisoprolol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bisoprolol USP).